Company Filing History:
Years Active: 2025
Title: Michael John Lambrecht: Innovator in Cancer Treatment
Introduction
Michael John Lambrecht is a notable inventor based in Burlingame, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Lambrecht holds a patent for "Lactams as CBL-B inhibitors selective over C-CBL." This compound, represented by formula (I), is designed to treat cancers that are susceptible to the inhibition of Cbl-B. His work in this area showcases his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Currently, Michael John Lambrecht is associated with Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His role at Genentech allows him to collaborate with some of the brightest minds in the industry.
Collaborations
Throughout his career, Lambrecht has worked alongside talented colleagues, including Malcolm Huestis and Jun Liang. These collaborations have further enriched his research and contributed to the development of groundbreaking treatments.
Conclusion
Michael John Lambrecht's work exemplifies the spirit of innovation in the medical field. His contributions to cancer treatment through his patent and collaborations highlight the importance of research in improving healthcare.